Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

German homecare association joins devices group:

This article was originally published in Clinica

Executive Summary

The German federal association for homecare (bvhc) last week voted to join the industry association for medical devices (BVMed), with a view to increasing its political influence within the healthcare market. BVMed has agreed to set up a homecare subdivision which will represent and oversee the bvhc's interests, covering legal rights, diabetes care, parenteral feeding, modern wound care, respiratory care, stoma/incontinence and medical aids for care homes. "We must be ready to respond to the increasingly pressurised situation in the healthcare sector. The synergy allows us to effectively combat the restrictive attitudes of the sickness funds with regard to reimbursement," said bvhc chairman Andreas Rudolph. The merger boosts BVMed's membership to over 200, representing a yearly turnover of DM8 billion ($3.5 billion).

You may also be interested in...



Canada Allows Exceptional Drug, Device Imports To Tackle COVID-19 Shortages

Medical products that do not fully comply with Canadian requirements but are manufactured according to comparable standards are being allowed into the country to deal with COVID-19-related shortages.

Canada Allows Exceptional Drug, Device Imports To Tackle COVID-19 Shortages

Medical products that do not fully comply with Canadian requirements but are manufactured according to comparable standards are being allowed into the country to deal with COVID-19-related shortages.

RECOVERY Coronavirus Study ‘Will Attract Global Players To UK’

A randomized COVID-19 study spanning the whole of the UK could help to bolster the UK’s reputation as a location for future clinical trials. It is also being seen partly as the result of the UK regulator's "decisive action" in fast-tracking trials for potential COVID-19 therapies.

Topics

UsernamePublicRestriction

Register

MT072117

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel